Loading clinical trials...

A Study to Evaluate the Effect of Musashino Diabetes Diet in Type II Diabetes Mellitus Disease | Clinical Trials | Clareo Health

COMPLETEDNA

A Study to Evaluate the Effect of Musashino Diabetes Diet in Type II Diabetes Mellitus Disease

NCT02446054•Celio Technology Inc.

View on ClinicalTrials.gov

Summary

Evaluation the change of patients' glycosylated hemoglobin (HbA1c) after 12 weeks diet control

Detailed Description

In this study, we provide the delivery service of Musashino T2DM diet for 12 weeks to patients with T2DM, to evaluate the effect on glycosylated hemoglobin (HbA1c), progression and compliance during study period.

Eligibility

Age

30 - 60 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•A baseline of glycosylated hemoglobin(HbA1c) is, 10%≥HbA1c≥7%, during past 1 month
•The subject is able to understand and comply with protocol requirements, instrument
•The subject and/or subject's primary caregiver is able to have the telephone interview use computer and internet assess
•Signed and dated written informed consent

Exclusion Criteria

•Pregnancy, breastfeeding or planning to become pregnant during the study
•Acute illness or infection requiring treatment within 14 days of study entry
•Other serious disease (e.g. Heart, lung, brain, liver) within 3 months
•Presence of malignancies
•Participate in other clinical trial within 30 days prior to this study
•Alcohol or drug abuse that would interfere with the ability to meet study requirements (opinion of investigator)
•Concurrent significant medical condition that would limit ability to participate in the study
•Consider by the investigator to be unsuitable for study participation, for any reason

Locations (1)

NTUH

Taipei, Taiwan

Key Dates

Start Date

February 1, 2014

Primary Completion Date

September 1, 2015

Completion Date

December 1, 2015

Last Updated

January 28, 2016

Enrollment

ACTUAL participants

Conditions

Type II Diabetes Mellitus

Interventions

Musashino T2DM diet

DIETARY_SUPPLEMENT

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors

NCT07350694

Diabetes Type 2Type II Diabetes Mellitus

View study

RECRUITINGNA

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D]

NCT06561126

Type II Diabetes MellitusIntermediate Hyperglycemia (IHG)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 28, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study to Evaluate the Effect of Musashino Diabetes Diet in Type II Diabetes Mellitus Disease

Inclusion Criteria

Exclusion Criteria

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D]

Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools

A Clinical Trial to Evaluate the Food Effect of CKD-379

An Observational Study Investigating the Effectiveness of Pravastatin on Renal Function in Korean Dyslipidemic Patients With Type 2 Diabetes

Assistive ExoSkeletons to Enable Wearable Rehabilitation Robotics